Kinamed CarboJet Study: Tourniquetless TKR May Decrease Pain, Opiod Use

Kinamed, developer of the CarboJet® CO2 Bone Preparation system, announced publication of a clinical study examining its use in traditional tourniquet vs. tourniquetless total knee replacement (TKR). Results indicate that female patients in the no-tourniquet/CarboJet group experienced significantly less post-op pain and consumed fewer opioids vs....

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us